ATE277943T1 - Trypsininhibitoren - Google Patents

Trypsininhibitoren

Info

Publication number
ATE277943T1
ATE277943T1 AT93905778T AT93905778T ATE277943T1 AT E277943 T1 ATE277943 T1 AT E277943T1 AT 93905778 T AT93905778 T AT 93905778T AT 93905778 T AT93905778 T AT 93905778T AT E277943 T1 ATE277943 T1 AT E277943T1
Authority
AT
Austria
Prior art keywords
trypsin inhibitors
trypsin
compounds
inhibitors
novel
Prior art date
Application number
AT93905778T
Other languages
English (en)
Inventor
Terence Kevin Brunck
Michael Gary Pepe
Daniel Andrew Pearson
Thomas Roy Webb
Original Assignee
Dendreon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dendreon Corp filed Critical Dendreon Corp
Priority claimed from US08/011,666 external-priority patent/US5534498A/en
Application granted granted Critical
Publication of ATE277943T1 publication Critical patent/ATE277943T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/06Compounds containing any of the groups, e.g. semicarbazides
    • C07C281/08Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones
    • C07C281/10Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones the carbon atom being further bound to an acyclic carbon atom or to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • C07K5/06113Asp- or Asn-amino acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT93905778T 1992-01-30 1993-01-29 Trypsininhibitoren ATE277943T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82838892A 1992-01-30 1992-01-30
US08/011,666 US5534498A (en) 1992-01-30 1993-01-29 Trypsin inhibitors
PCT/US1993/000906 WO1993014779A1 (en) 1992-01-30 1993-01-29 Trypsin inhibitors

Publications (1)

Publication Number Publication Date
ATE277943T1 true ATE277943T1 (de) 2004-10-15

Family

ID=26682650

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93905778T ATE277943T1 (de) 1992-01-30 1993-01-29 Trypsininhibitoren

Country Status (7)

Country Link
US (1) US5714580A (de)
EP (1) EP0627925B1 (de)
JP (1) JPH07503715A (de)
AT (1) ATE277943T1 (de)
CA (1) CA2128711C (de)
DE (1) DE69333639D1 (de)
WO (1) WO1993014779A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2129339C (en) * 1992-02-14 2002-09-10 George P. Vlasuk Inhibitors of thrombosis
WO1994017817A1 (en) * 1993-02-12 1994-08-18 Corvas International, Inc. Inhibitors of thrombosis
US5656600A (en) * 1993-03-25 1997-08-12 Corvas International, Inc. α-ketoamide derivatives as inhibitors of thrombosis
US6046169A (en) * 1995-06-07 2000-04-04 Cor Therapeutics, Inc. Inhibitors of factor XA
US5919765A (en) * 1995-06-07 1999-07-06 Cor Therapeutics, Inc. Inhibitors of factor XA
US6069130A (en) 1995-06-07 2000-05-30 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US5721214A (en) * 1995-06-07 1998-02-24 Cor Therapeutics, Inc. Inhibitors of factor Xa
US6022861A (en) * 1995-06-07 2000-02-08 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US5856571A (en) * 1995-06-07 1999-01-05 Cellpro, Incorporated Semicarbazide-containing linker compounds for formation of stably-linked conjugates and methods related thereto
US6211154B1 (en) * 1995-06-07 2001-04-03 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6245743B1 (en) 1996-06-05 2001-06-12 Cor Therapeutics, Inc. Inhibitors of factor Xa
US6087558A (en) * 1998-07-22 2000-07-11 Prodigene, Inc. Commercial production of proteases in plants
US6787612B1 (en) 1998-07-24 2004-09-07 Dendreon Corporation Resin derivatization method and uses thereof
AU2285700A (en) * 1999-01-02 2000-07-24 Aventis Pharma Deutschland Gmbh Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them
US6677473B1 (en) 1999-11-19 2004-01-13 Corvas International Inc Plasminogen activator inhibitor antagonists
US6800728B2 (en) * 2000-03-22 2004-10-05 Solulink Biosciences, Inc. Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
US6872827B2 (en) 2002-04-26 2005-03-29 Chembridge Research Laboratories, Inc. Somatostatin analogue compounds
WO2010132954A1 (en) * 2009-05-21 2010-11-25 Oral Health Australia Pty Ltd Method of treating periodontal disease by administering antagonists of par-2
MY162557A (en) 2010-02-26 2017-06-15 Oral Health Australia Pty Ltd Treatment or prevention of infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
CA2129339C (en) * 1992-02-14 2002-09-10 George P. Vlasuk Inhibitors of thrombosis

Also Published As

Publication number Publication date
EP0627925B1 (de) 2004-09-29
WO1993014779A1 (en) 1993-08-05
US5714580A (en) 1998-02-03
JPH07503715A (ja) 1995-04-20
CA2128711A1 (en) 1993-08-05
DE69333639D1 (en) 2004-11-04
CA2128711C (en) 2005-01-11
EP0627925A4 (de) 1997-07-30
EP0627925A1 (de) 1994-12-14

Similar Documents

Publication Publication Date Title
ATE277943T1 (de) Trypsininhibitoren
ATE277612T1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
NO954722D0 (no) Peptid inhibitorer med urokinase reseptoraktivitet
TR199801151T2 (xx) Trombin inhibit�r� �n ila�lar.
MY129998A (en) Saccharin derivative proteolytic enzyme inhibitors
DK0661992T3 (da) Farmaceutiske sammensætninger med interleukin-1 inhibitorer
PL319782A1 (en) Inhibitors of serinic proteases and anticoagulative protecins extracted from nematodes
DK0813867T3 (da) Retrovirale proteaseinhibitorer
MX9207449A (es) Inhibidores de la enzima proteolitica derivada de sacarina.
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
TR199902751T2 (xx) Proteaz inhibit�rleri.
DK0460062T3 (da) Huperzin A-analoger
EE9900477A (et) Ühendid ja kompositsioonid seriinproteaasse, eriti trüptaasse aktiivsusega seotud haiguste raviks
DE69429816D1 (de) C1-Esterasehemmer zur Verringerung von Myokardschäden bei akutem Herzinfarkt
GB9930768D0 (en) Composition
DE69332904D1 (de) Hemmung von hiv-infektion
ATE255594T1 (de) Hepatitis b inhibitoren
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ES2103482T3 (es) Antigeno de linfocitos t citotoxicos utilizado como inhibidor de la cisteina proteasa.
ATE321143T1 (de) Genexpression in monocyten und makrophagen
ES2190456T3 (es) Combinacion de inhibidores de la proteasa del vih.
ATE308339T1 (de) Kombination der proteolytischen enzyme trypsin, bromelain und papain zur behandlung von glomerulonephritis
DE69815143D1 (de) Behandlung von allergischen zuständen mit cystein- und serin-proteinase inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties